In contrast, Zhou et al. documented the OA proapoptotic activity by the up-regulation of Bcl-2 proapoptotic protein and down-regulation of the anti-apoptotic Bax protein in SMMC-7721 hepatocellular carcinoma cells, thus significantly inhibiting HCC proliferation in a dose-dependent manner. This evidence concerns the gene BCL2 and hepatocellular carcinoma.